Brain scans probe MS Drug's potential for schizophrenia
NCT ID NCT06957808
Summary
This study is testing if a drug called diroximel fumarate, currently used for multiple sclerosis, can increase levels of a protective brain chemical called glutathione in people with schizophrenia. Researchers will use brain scans and other tests on 30 participants to see if the drug changes this chemical and if those changes relate to symptoms. The goal is to gather information to design better future treatments for this serious mental health condition.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SCHIZOPHRENIA DISORDERS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Email: •••••@•••••
Locations
-
Department of Computer Science, Faculty of Engineering Science, University College London
RECRUITINGLondon, Greater London, WC1E 6BT, United Kingdom
Contact Email: •••••@•••••
Contact
-
School of Psychology, University of birmingham
RECRUITINGBirmingham, B15 2TT, United Kingdom
Contact Email: •••••@•••••
Contact
-
South London and Maudsley NHS Foundation Trust
RECRUITINGLondon, Greater London, SE58AZ, United Kingdom
Contact
Contact
Contact
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.